Skip to main content
University of Wisconsin–Madison
UW Crest
Wisconsin Head and Neck Cancer SPORE
A collaborative cancer research project
  • Home
  • About Us Expand Collapse
    • Overview
    • SPORE Leaders
    • Patient Advocates
  • Head and Neck Cancer Research Expand Collapse
    • Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
    • Project 2: Predicting Treatment Responses Using Single Cell RNA Sequencing and Bioengineered Patient-derived Organotypic Models of HNC
    • Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
    • Awarded CEP Pilots
    • Awarded DRP Pilots
    • SPORE Supported Publications
  • Resources Expand Collapse
    • Citing the Wisconsin Head and Neck SPORE
    • Intranet Access
    • Administrative Core
    • Biostatistics and Informatics Core
    • Pathology and Biospecimen Core
  • Funding Opportunities Expand Collapse
    • Submit Letter of Intent for Head and Neck SPORE Pilot Funding
    • Career Enhancement Program (CEP)
    • Developmental Research Program (DRP)
  • Give A Gift
  1. Home
  2. Resources

Resources

Head & Neck Cancer News

FDA Approves Pembrolizumab for Head and Neck Cancer

UW Carbone Cancer Center

HN Cancer SPOREs

Cancer Genome Atlas

Head and Neck Cancer Fact Sheet

Head and Neck Cancer Clinical Trials

Cancer.net

Site footer content

University logo that links to main university website Part of the Universities of Wisconsin

Resources & Programs

  • Admin Core
  • Biostats Core
  • Path Core
  • Career Enhancement Program (CEP)
  • Developmental Research Program (DRP)

Helpful links

  • Cite the Wisconsin Head & Neck SPORE
  • SPORE Supported Publications

Website feedback, questions or accessibility issues: webmaster@humonc.wisc.edu | Learn more about accessibility at UW–Madison.

This site was built using the UW Theme | Privacy Notice | © 2025 Board of Regents of the University of Wisconsin System.